Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

ObjectiveSuicidal behavior is heritable and is a major cause of death worldwide. Two large-scale genome-wide association studies (GWASs) recently discovered and cross-validated genome-wide significant (GWS) loci for suicide attempt (SA). The present study leveraged the genetic cohorts from both studies to conduct the largest GWAS meta-analysis of SA to date. Multi-ancestry and admixture-specific meta-analyses were conducted within groups of significant African, East Asian, and European ancestry admixtures.MethodsThis study comprised 22 cohorts, including 43,871 SA cases and 915,025 ancestry-matched controls. Analytical methods across multi-ancestry and individual ancestry admixtures included inverse variance-weighted fixed-effects meta-analyses, followed by gene, gene-set, tissue-set, and drug-target enrichment, as well as summary-data-based Mendelian randomization with brain expression quantitative trait loci data, phenome-wide genetic correlation, and genetic causal proportion analyses.ResultsMulti-ancestry and European ancestry admixture GWAS meta-analyses identified 12 risk loci at p values <5×10-8. These loci were mostly intergenic and implicated DRD2, SLC6A9, FURIN, NLGN1, SOX5, PDE4B, and CACNG2. The multi-ancestry SNP-based heritability estimate of SA was 5.7% on the liability scale (SE=0.003, p=5.7×10-80). Significant brain tissue gene expression and drug set enrichment were observed. There was shared genetic variation of SA with attention deficit hyperactivity disorder, smoking, and risk tolerance after conditioning SA on both major depressive disorder and posttraumatic stress disorder. Genetic causal proportion analyses implicated shared genetic risk for specific health factors.ConclusionsThis multi-ancestry analysis of suicide attempt identified several loci contributing to risk and establishes significant shared genetic covariation with clinical phenotypes. These findings provide insight into genetic factors associated with suicide attempt across ancestry admixture populations, in veteran and civilian populations, and in attempt versus death.

Original publication

DOI

10.1176/appi.ajp.21121266

Type

Journal article

Journal

The American journal of psychiatry

Publication Date

10/2023

Volume

180

Pages

723 - 738

Addresses

Huntsman Mental Health Institute, Salt Lake City (Docherty, Shabalin, Murnyak, DiBlasi, Coon); Department of Psychiatry (Docherty, Shabalin, Murnyak, DiBlasi, Bakian, Monson, Coon), Department of Pathology (Christensen), and Biomedical Informatics (Coon), University of Utah School of Medicine, Salt Lake City; Department of Psychiatry, Virginia Commonwealth University, Richmond (Docherty, Edwards, Bigdeli, Kendler); Department of Genetics and Genomic Sciences (Mullins, Pinto, Sklar, Stahl), Department of Psychiatry (Mullins, Pinto, Kahn, Sklar), and Department of Neuroscience (Sklar), Icahn School of Medicine at Mount Sinai, New York; Duke Molecular Physiology Institute (Ashley-Koch, Qin, E.R. Hauser, M.A. Hauser), Department of Psychiatry and Behavioral Sciences (Dennis), and Duke Molecular Physiology Institute (Garrett), Duke University Medical Center, Durham, N.C.; NIHR Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust, King's College London (Coleman, Breen); Social Genetic and Developmental Psychiatry Centre, King's College London (Coleman, McGuffin, Power, Rivera, Breen, Lewis); Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, and Vanderbilt Genetics Institute, Nashville, Tenn. (Kang, Ruderfer); Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tenn. (Ruderfer); Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, Tenn. (Ruderfer); Department of Psychiatry (Wendt, Polimanti) and Division of Human Genetics, Department of Psychiatry (Levey, Gelernter), Yale University School of Medicine, New Haven, Conn.; Division of Psychiatry (Adams, Hafferty, McIntosh), Institute for Genetics and Molecular Medicine (Porteous), and Centre for Clinical Brain Sciences (Smith), University of Edinburgh, Edinburgh; Mental Health and Neuroscience Research Program (Campos, Rentería, Martin, Medland) and Department of Population Health (Olsen, Whiteman), QIMR Berghofer Medical Research Institute, Brisbane, Australia; Institute for Molecular Bioscience (Campos, Byrne, Trzaskowski, Wray), School of Biomedical Sciences, Faculty of Medicine (Rentería), Child Health Research Centre (Byrne), and Queensland Brain Institute (Mehta, Wray), University of Queensland, Brisbane, Australia; Neuroscience Research Australia, Sydney (Fullerton, Gatt, Green, Schofield, C.S. Weickert, T.W. Weickert); School of Medical Sciences (Fullerton, Schofield), School of Psychology (Bryant, Gatt), and School of Psychiatry (P.B. Mitchell, Green, G. Roberts, C.S. Weickert, T.W. Weickert), University of New South Wales, Sydney, Australia; Department of Psychiatry (Kranzler, Oslin), Center for Neurobiology and Behavior, Department of Psychiatry (Berrettini), and Center for Applied Genomics and Department of Pediatrics (Hakonarson), Perelman School of Medicine, University of Pennsylvania, Philadelphia; Crescenz VAMC, VISN 4 MIRECC, Philadelphia (Kranzler); Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center, Houston (Walss-Bass); Division of Mental Health and Addiction (Andreassen, Melle, Smeland) and Department of Medical Genetics (Djurovic), Oslo University Hospital, Oslo; NORMENT, University of Oslo, Oslo (Andreassen, Smeland); Department of Forensic Medicine, All-India Institute for Medical Sciences, Delhi (Behera); Department of Medical Epidemiology and Biostatistics (Bulik, Landén), National Centre for Suicide Research and Prevention of Mental Ill-Health (NASP), LIME (Sokolowski, Wasserman), Department of Clinical Neuroscience, Centre for Psychiatry Research (Agartz), Department of Clinical Neuroscience (Alfredsson), and Institute of Environmental Medicine (Alfredsson), Karolinska Institutet, Stockholm; Department of Nutrition (Bulik), Department of Psychiatry (Bulik, Thornton, Watson, Yilmaz), and Department of Genetics (Yilmaz), University of North Carolina at Chapel Hill;

Keywords

VA Million Veteran Program (MVP), MVP Suicide Exemplar Workgroup, Suicide Working Group of the Psychiatric Genomics Consortium, Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, Bipolar Disorder Working Group of the Psychiatric Genomics Consortium, Schizophrenia Working Group of the Psychiatric Genomics Consortium, Eating Disorder Working Group of the Psychiatric Genomics Consortium, German Borderline Genomics Consortium, Humans, Genetic Predisposition to Disease, Risk Factors, Suicide, Attempted, Depressive Disorder, Major, Polymorphism, Single Nucleotide, Genome-Wide Association Study, Genetic Loci, Suicidal Ideation